SEC Info - Nextgen Healthcare, Inc.

SEC Info℠

Home

My Interests

Help

Please Sign In

Nextgen Healthcare, Inc.
CA
SEC # 708818

Click to view...

Registrant

About

Filings

Files

Relationships

Names

Topics

Web

*As Of*	*Filing*	*Page*	*Title*	*Docs.*

10/6/23	DEFM14A	1	A- 11	2
		1	A-1	2
		1	A-10	2
		1	A-12	2
		1	A-13	2
		1	A-19	2
		1	A-20	2
		1	A-21	2
		1	A-22	2
		1	A-24	2
		1	A-26	2
		1	A-27	2
		1	A-28	2
		1	A-29	2
		1	A-30	2
		1	A-31	2
		1	A-32	2
		1	A-33	2
		1	A-34	2
		1	A-35	2
		1	A-36	2
		1	A-37	2
		1	A-38	2
		1	A-40	2
		1	A-41	2
		1	A-42	2
		1	A-44	2
		1	A-45	2
		1	A-47	2
		1	A-48	2
		1	A-50	2
		1	A-51	2
		1	A-54	2
		1	A-55	2
		1	A-56	2
		1	A-57	2
		1	A-59	2
		1	A-61	2
		1	A-62	2
		1	A-63	2
		1	A-64	2
		1	A-65	2
		1	A-66	2
		1	A-68	2
		1	A-69	2
		1	Absence of Certain Arrangements	2
		1	Absence of Certain Changes	2
		1	Access	2
10/24/23	10-Q	1	Accounts Receivable	3
10/6/23	DEFM14A	1	Additional Definitions	2
		1	Amended and Restated Bylaws of the Surviving Corporation	2
		1	Amended and Restated Certificate of Incorporation of the Surviving Corporation	2
		1	Amendment	2
7/26/23	DEF 14A	1	Annex A -- Full Text of Amendment and Restatement to 2015 Equity Incentive Plan	1
10/6/23	DEFM14A	1	Annex A-1 -- Amended and Restated Certificate of Incorporation of the Surviving Corporation	2
		1	Annex A-2 -- Amended and Restated Bylaws of the Surviving Corporation	2
		1	Annex A-Agreement and Plan of Merger	2
		1	Annex B-Opinion of Morgan Stanley & Co. Llc	2
7/26/23	DEF 14A	1	Annual Report and Available Information	1
10/6/23	DEFM14A	1	Anti-Takeover Laws	2
		1	Antitrust Obligations	2
		1	Article I DEFINITIONS & INTERPRETATIONS	2
		1	Article II THE MERGER	2
		1	Article III REPRESENTATIONS AND WARRANTIES OF THE COMPANY	2
		1	Article IV REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB	2
		1	Article IX GENERAL PROVISIONS	2
		1	Article V COVENANTS OF THE COMPANY	2
		1	Article VI ADDITIONAL COVENANTS	2
		1	Article VII CONDITIONS TO THE MERGER	2
		1	Article VIII TERMINATION, AMENDMENT AND WAIVER	2
		1	Assignment	2
7/26/23	DEF 14A	1	Audit and Non-Audit Fees	1
		1	Auditor Independence	1
10/6/23	DEFM14A	1	Authority	2
		1	B- 1	2
7/26/23	DEF 14A	1	Board Committees and Charters	1
		1	Board of Directors	1
10/6/23	DEFM14A	1	Brokers	2
		1	Brokers; Certain Expenses	2
5/22/23	10-K	1	Business	1
10/24/23	10-Q	1	Business Combinations and Disposals	3
10/6/23	DEFM14A	1	Capitalization	2
10/24/23	10-Q	1	Capitalized Software Costs	3
7/26/23	DEF 14A	1	Cautionary Note Concerning Forward Looking Statements	1
10/6/23	DEFM14A	1	Cautionary Statement Regarding Forward-Looking Statements	2
7/26/23	DEF 14A	1	CEO Pay Ratio	1
10/6/23	DEFM14A	1	Certain Definitions	2
		1	Certain Interpretations	2
		1	Certain Litigation	2
		1	Certain Payments	2
7/26/23	DEF 14A	1	Certain Relationships and Related Person Transactions	1
5/22/23	10-K	1	Certain Relationships and Related Transactions, and Director Independence	1
10/6/23	DEFM14A	1	Certificate of Incorporation and Bylaws	2
5/22/23	10-K	1	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	1
10/6/23	DEFM14A	1	Closing, The	2
10/24/23	10-Q	1	Commitments, Guarantees and Contingencies	3
10/6/23	DEFM14A	1	Companies, The	2
		1	Company Board Recommendation	2
7/26/23	DEF 14A	1	Compensation Committee Interlocks and Insider Participation	1
		1	Compensation Committee Report	1
		1	Compensation Discussion and Analysis	1
10/6/23	DEFM14A	1	Compliance with Law; Permits	2
10/24/23	10-Q	1	Composition of Certain Financial Statement Captions	3
		1	Concentration of Credit Risk	2
10/6/23	DEFM14A	1	Conditions to the Obligations of Each Party	2
		1	Conditions to the Obligations of Parent and Merger Sub	2
		1	Conditions to the Obligations of the Company	2
		1	Conduct of Business of the Company	2
		1	Confidentiality	2
		1	Consent to Jurisdiction	2
		1	Consents and Approvals; No Violation	2
5/22/23	10-K	1	Consolidated Balance Sheets as of March 31, 2023 and 2022	1
		1	Consolidated Statements of Cash Flows -- Years Ended March 31, 2023, 2022 and 2021	1
		1	Consolidated Statements of Net Income and Comprehensive Income -- Years Ended March 31, 2023, 2022 and 2021	1
		1	Consolidated Statements of Shareholders' Equity -- Years Ended March 31, 2023, 2022 and 2021	1
10/24/23	10-Q	1	Controls and Procedures	3
10/6/23	DEFM14A	1	Convertible Notes	2
7/26/23	DEF 14A	1	Corporate Governance	1
10/6/23	DEFM14A	1	Corporate Power; Enforceability	2
7/26/23	DEF 14A	1	Corporate Social Responsibility	1
10/6/23	DEFM14A	1	Counterparts	2
10/24/23	10-Q	1	Debt	3
10/6/23	DEFM14A	1	Debt Financing Sources	2
10/24/23	10-Q	1	Defaults Upon Senior Securities	2
10/6/23	DEFM14A	1	Delisting	2
7/26/23	DEF 14A	1	Director Compensation	1
		1	Directors	1
10/6/23	DEFM14A	1	Directors and Officers	2
		1	Directors' and Officers' Indemnification and Insurance	2
5/22/23	10-K	1	Directors, Executive Officers and Corporate Governance	1
10/6/23	DEFM14A	1	Disclosure Letter References	2
5/22/23	10-K	1	Disclosure Regarding Foreign Jurisdictions that Prevent Inspections	1
10/24/23	10-Q	1	Earnings Per Share	2
10/6/23	DEFM14A	1	Effect of the Merger	2
		1	Effect on Capital Stock	2
		1	Effective Time, The	2
		1	Employee Benefit Matters/Employees	2
5/22/23	10-K	1	Employee Benefit Plans	1
10/6/23	DEFM14A	1	Employee Matters	2
		1	Entire Agreement	2
		1	Environmental Matters	2
7/26/23	DEF 14A	1	Equity Compensation Plan Information	1
10/6/23	DEFM14A	1	Equity Financing	2
7/26/23	DEF 14A	1	Executive and Director Compensation and Related Information	1
5/22/23	10-K	1	Executive Compensation	1
10/24/23	10-Q	1	Exhibits	2
5/22/23	10-K	1	Exhibits and Financial Statement Schedules	1
10/6/23	DEFM14A	1	Extension; Waiver	2
10/24/23	10-Q	1	Fair Value Measurements	3
10/6/23	DEFM14A	1	Fees and Expenses	2
10/24/23	10-Q	1	Financial Statements	2
5/22/23	10-K	1	Financial Statements and Supplementary Data	1
10/6/23	DEFM14A	1	Financing Cooperation	2
5/22/23	10-K	1	Form 10-K Summary	1
7/26/23	DEF 14A	1	Full Text of Amendment and Restatement to 2015 Equity Incentive Plan	1
10/6/23	DEFM14A	1	Further Actions	2
		1	Future Stockholder Proposals	2
10/24/23	10-Q	1	Goodwill	3
10/6/23	DEFM14A	1	Governing Law	2
7/26/23	DEF 14A	1	Grants of Plan-Based Awards for Fiscal Year Ended March 31, 2023	1
10/6/23	DEFM14A	1	Health Care Matters	2
7/26/23	DEF 14A	1	Householding of Annual Meeting Materials	1
10/24/23	10-Q	1	Income Taxes	3
5/22/23	10-K	1	Index to Exhibits	1
7/26/23	DEF 14A	1	Information About Our Board of Directors, Board Committees and Related Matters	1
10/6/23	DEFM14A	1	Insurance	2
10/24/23	10-Q	1	Intangible Assets	3
10/6/23	DEFM14A	1	Intellectual Property	2
		1	Interested Stockholder	2
10/24/23	10-Q	1	Investments	2
		1	Leases	3
		1	Legal Proceedings	3
10/6/23	DEFM14A	1	Litigation	2
		1	Lost, Stolen or Destroyed Certificates	2
10/24/23	10-Q	1	Management's Discussion and Analysis of Financial Condition and Results of Operations	3
5/22/23	10-K	1	Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	1
10/6/23	DEFM14A	1	Market Prices and Dividend Data	2
5/22/23	10-K	1	Marketable Securities	1
10/6/23	DEFM14A	1	Material Contracts	2
		1	Merger Agreement, The	2
		1	Merger, The	2
5/22/23	10-K	1	Mine and Safety Disclosures	1
10/24/23	10-Q	1	Mine Safety Disclosure	2
10/6/23	DEFM14A	1	Miscellaneous	2
		1	No Further Ownership Rights in Company Shares	2
		1	No Other Operations	2
		1	No Other Representations or Warranties	2
		1	No Presumption Against Drafting Party	2
		1	No Recourse	2
		1	No Solicitation	2
		1	No Undisclosed Liabilities	2
7/26/23	DEF 14A	1	Non-Director Executive Officers	1
		1	Nonqualified Deferred Compensation for Fiscal Year Ended March 31, 2023	1
5/22/23	10-K	1	Notes to Consolidated Financial Statements	1
10/24/23	10-Q	1	Notes to Unaudited Condensed Consolidated Financial Statements	2
7/26/23	DEF 14A	1	Notice of Internet Availability of Proxy Materials	1
10/6/23	DEFM14A	1	Notice of Termination; Effect of Termination	2
		1	Notices	2
		1	Obligations of Merger Sub	2
		1	Opinion of Financial Advisors of the Company	2
7/26/23	DEF 14A	1	Option Exercises and Stock Vested During Fiscal Year Ended March 31, 2023	1
10/6/23	DEFM14A	1	Organization and Qualification	2
5/22/23	10-K	1	Organization of Business	1
10/24/23	10-Q	1	Other Information	3
7/26/23	DEF 14A	1	Other Matters	1
		1	Outstanding Equity Awards at Fiscal Year Ended March 31, 2023	1
		1	Outstanding Shares and Voting	1
10/6/23	DEFM14A	1	Parent Stockholder Consent	2
5/22/23	10-K	1	Part I	1
10/24/23	10-Q	1	Part I. Financial Information	2
5/22/23	10-K	1	Part Ii	1
10/24/23	10-Q	1	Part Ii. Other Information	2
5/22/23	10-K	1	Part Iii	1
		1	Part Iv	1
7/26/23	DEF 14A	1	Pay Versus Performance Table	1
		1	Pension Benefits	1
		1	Policy on Audit Committee Pre-Approval of Audit and Non-Audit Services	1
		1	Potential Payments Upon Termination of Employment in Change-in-Control	1
5/22/23	10-K	1	Principal Accountant Fees and Services	1
		1	Properties	1
10/6/23	DEFM14A	1	Proposal No. 1: Approval of the Merger Proposal	2
7/26/23	DEF 14A	1	Proposal No. 1: ELECTION OF DIRECTORS	1
10/6/23	DEFM14A	1	Proposal No. 2: Advisory Vote on the Merger Compensation Proposal	2
7/26/23	DEF 14A	1	Proposal No. 2: RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM	1
10/6/23	DEFM14A	1	Proposal No. 3: Adjournment of the Special Meeting	2
7/26/23	DEF 14A	1	Proposal No. 4: AMENDMENT AND RESTATEMENT OF 2015 AMENDED EQUITY INCENTIVE PLAN	1
10/6/23	DEFM14A	1	Proxy Statement; Company Stockholder Meeting	2
		1	Public Statements and Disclosure	2
10/24/23	10-Q	1	Quantitative and Qualitative Disclosures about Market Risk	2
5/22/23	10-K	1	Quantitative and Qualitative Disclosures about Market Risks	1
10/6/23	DEFM14A	1	Questions and Answers	2
		1	Real Property; Assets	2
		1	Reasonable Best Efforts	2
7/26/23	DEF 14A	1	Related Matters	1
10/6/23	DEFM14A	1	Related Party Transactions	2
7/26/23	DEF 14A	1	Related Person Transactions	1
10/6/23	DEFM14A	1	Remedies	2
5/22/23	10-K	1	Report of Independent Registered Public Accounting Firm (PCAOB ID 238 )	1
10/6/23	DEFM14A	1	Reports; Financial Statements	2
5/22/23	10-K	1	Reserved	1
		1	Restructuring Plan	1
10/24/23	10-Q	1	Revenue from Contracts with Customers	3
7/26/23	DEF 14A	1	Review, Approval or Ratification of Transactions with Related Persons	1
10/24/23	10-Q	1	Risk Factors	3
7/26/23	DEF 14A	1	Say-On-Pay	1
5/22/23	10-K	1	Schedule II -- Valuation and Qualifying Accounts -- Years Ended March 31, 2023, 2022 and 2021	1
10/6/23	DEFM14A	1	Section 16(b) Exemption	2
		1	Security Ownership of Certain Beneficial Owners and Management	3
5/22/23	10-K	1	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	1
10/6/23	DEFM14A	1	Severability	2
10/24/23	10-Q	1	Signatures	3
7/26/23	DEF 14A	1	Solicitation of Proxies	1
10/6/23	DEFM14A	1	Solvency	2
		1	Special Meeting, The	2
		1	State Takeover Statutes Inapplicable	2
		1	Stockholder Approval	2
10/24/23	10-Q	1	Stockholders' Equity	3
10/6/23	DEFM14A	1	Subsidiaries	2
		1	Summary	2
7/26/23	DEF 14A	1	Summary Compensation Table for Fiscal Year Ended March 31, 2023	1
10/24/23	10-Q	1	Summary of Significant Accounting Policies	3
10/6/23	DEFM14A	1	Survival of Representations, Warranties and Covenants	2
		1	Table of Contents	3
		1	Tax Matters	2
		1	Termination Prior to the Effective Time	2
		1	The Closing	2
		1	The Companies	2
		1	The Effective Time	2
		1	The Merger	2
		1	The Merger Agreement	2
		1	The Special Meeting	2
		1	Third Party Beneficiaries	2
		1	Trade Control Laws	2
		1	Transfer Taxes	2
7/24/23	10-Q	1	Unaudited Condensed Consolidated Balance Sheets as of June 30, 2023 and March 31, 2023	1
10/24/23	10-Q	1	Unaudited Condensed Consolidated Balance Sheets as of September 30, 2023 and March 31, 2023	1
		1	Unaudited Condensed Consolidated Statements of Cash Flows for the six months ended September 30, 2023 and 2022	1
7/24/23	10-Q	1	Unaudited Condensed Consolidated Statements of Cash Flows for the three months ended June 30, 2023 and 2022	1
10/24/23	10-Q	1	Unaudited Condensed Consolidated Statements of Net Income and Comprehensive Income for the six months ended September 30, 2023 and 2022	1
7/24/23	10-Q	1	Unaudited Condensed Consolidated Statements of Net Income and Comprehensive Income for the three months ended June 30, 2023 and 2022	1
10/24/23	10-Q	1	Unaudited Statements of Condensed Consolidated Stockholders' Equity for the six months ended September 30, 2023 and 2022	1
7/24/23	10-Q	1	Unaudited Statements of Condensed Consolidated Stockholders' Equity for the three months ended June 30, 2023 and 2022	1
10/24/23	10-Q	1	Unregistered Sales of Equity Securities and Use of Proceeds	2
5/22/23	10-K	1	Unresolved Staff Comments	1
		1	Valuation and Qualifying Accounts -- Years Ended March 31, 2023, 2022 and 2021	1
10/6/23	DEFM14A	1	Waiver of Jury Trial	2
		1	Where You Can Find More Information	2
5/22/23	10-K	1	Years Ended March 31, 2023, 2022 and 2021	1
10/6/23	DEFM14A	1	1.1	2
		1	1.2	2
		1	1.3	2
		1	101	2
		1	102	2
		1	104	2
		1	2.1	2
		1	2.10	2
		1	2.2	2
		1	2.3	2
		1	2.4	2
		1	2.5	2
		1	2.6	2
		1	2.7	2
		1	2.8	2
		1	2.9	2
		1	3.1	2
		1	3.10	2
		1	3.11	2
		1	3.12	2
		1	3.13	2
		1	3.14	2
		1	3.15	2
		1	3.16	2
		1	3.17	2
		1	3.18	2
		1	3.19	2
		1	3.2	2
		1	3.20	2
		1	3.21	2
		1	3.22	2
		1	3.23	2
		1	3.24	2
		1	3.25	2
		1	3.26	2
		1	3.3	2
		1	3.4	2
		1	3.5	2
		1	3.6	2
		1	3.7	2
		1	3.8	2
		1	3.9	2
		1	4.1	2
		1	4.10	2
		1	4.11	2
		1	4.2	2
		1	4.3	2
		1	4.4	2
		1	4.5	2
		1	4.6	2
		1	4.7	2
		1	4.8	2
		1	4.9	2
		1	5.1	2
		1	5.2	2
		1	5.3	2
		1	5.4	2
		1	6.1	2
		1	6.10	2
		1	6.11	2
		1	6.12	2
		1	6.13	2
		1	6.14	2
		1	6.15	2
		1	6.2	2
		1	6.3	2
		1	6.4	2
		1	6.5	2
		1	6.6	2
		1	6.7	2
		1	6.8	2
		1	6.9	2
		1	7.1	2
		1	7.2	2
		1	7.3	2
		1	8.1	2
		1	8.2	2
		1	8.3	2
		1	8.4	2
		1	8.5	2
		1	8.6	2
		1	9.1	2
		1	9.10	2
		1	9.11	2
		1	9.12	2
		1	9.13	2
		1	9.14	2
		1	9.15	2
		1	9.16	2
		1	9.2	2
		1	9.3	2
		1	9.4	2
		1	9.5	2
		1	9.6	2
		1	9.7	2
		1	9.8	2
		1	9.9	2

↑Top

Nextgen Healthcare, Inc. CA SEC # 708818

707 Topics within the Past Year Past Two Years Past Three Years Past Four Years Past Five Years Entire Database

Nextgen Healthcare, Inc.
CA
SEC # 708818

707 Topics
within the